The Cell Salt Co. Daily Blend 12 In 1 Tablet, Soluble
NDC Package 87674-100-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

The Cell Salt Co. Daily Blend 12 In 1 (calc fluor, calc phos, calc sulph, ferrum phos, kali mur, kali phos, kali sulph, mag phos, nat mur, nat phos, nat sulph, silicea) tablets is use as directed.Adults and children 6 years and over: Dissolve 1 tablet under tongue 3 times per day. This formulation utilizes a tablet, soluble delivery system. Marketed by The Cell Salt Company Llc, this product is identified by NDC 87674-100.

Identification & Billing

NDC Package Code
87674-100-10
Package Description
400 TABLET, SOLUBLE in 1 BOTTLE
Product Code
87674-100
11-Digit Billing Format
87674010010

Clinical Specifications

Proprietary Name
The Cell Salt Co. Daily Blend 12 In 1
Non-Proprietary Name
Calc Fluor, Calc Phos, Calc Sulph, Ferrum Phos, Kali Mur, Kali Phos, Kali Sulph, Mag Phos, Nat Mur, Nat Phos, Nat Sulph, Silicea
Substance Name
Calcium Fluoride; Calcium Sulfate Anhydrous; Ferrosoferric Phosphate; Magnesium Phosphate, Dibasic Trihydrate; Potassium Chloride; Potassium Phosphate; Potassium Sulfate; Silicon Dioxide; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate; Sodium Sulfate; Tribasic Calcium Phosphate
Dosage Form
Tablet, Soluble - A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Use as directed.Adults and children 6 years and over: Dissolve 1 tablet under tongue 3 times per day.

Regulatory & Marketing

Labeler Name
The Cell Salt Company Llc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
07-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87674-100-10 identifies a specific commercial package of 400 tablet, soluble in 1 bottle of The Cell Salt Co. Daily Blend 12 In 1, a human over the counter drug labeled by The Cell Salt Company Llc. This tablet, soluble is formulated for oral use and contains calcium fluoride; calcium sulfate anhydrous; ferrosoferric phosphate; magnesium phosphate, dibasic trihydrate; potassium chloride; potassium phosphate; potassium sulfate; silicon dioxide; sodium chloride; sodium phosphate, dibasic, heptahydrate; sodium sulfate; tribasic calcium phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Cell Salt Company Llc on July 01, 2026. The current certification is valid through December 31, 2027.

How is this The Cell Salt Company Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87674010010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87674-100-10
11-Digit CMS (5-4-2)
87674-0100-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.